PEN — Penumbra Inc
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1321732 ·
Last close
$319.18
Market Cap
$12.57B
52W High
$362.41
52W Low
$221.26
ADV30
343,672
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 390,046,000 | 264,944,000 | 41,039,000 | 34,811,000 | 1,974,723,000 | 205,271,000 | 443,957,000 |
| Mar 2026 | 374,758,000 | 253,411,000 | 38,234,000 | 32,584,000 | 1,898,438,000 | 241,289,000 | 424,626,000 |
| Dec 2025 | 385,385,000 | 262,128,000 | 59,233,000 | 47,343,000 | 1,826,519,000 | 186,897,000 | 398,916,000 |
| Sep 2025 | 354,685,000 | 240,416,000 | 48,838,000 | 45,851,000 | 1,744,369,000 | 321,029,000 | 385,673,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$277,802,000
Investing CF
$-510,232,000
Financing CF
$16,125,000
CapEx
$-61,896,000
Dividends Paid
—
Buybacks
$1,000
EPS Diluted TTM
$4.07
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$305,086,000
Inventory
$442,650,000
Receivables
$190,407,000
ST Investments
$453,524,000
EBIT TTM
$205,131,000
Pretax Income TTM
$203,832,000
Interest Exp TTM
$1,299,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,504,873,984
EBITDA
$204,282,000
Free Cash Flow
$161,100,128
Enterprise Value
$12,069,115,904
Total Cash
$658,795,008
Total Debt
$212,710,000
Shares Out
39,389,422
Trailing EPS
$4.07
Book Value
$38.86
ROE
11.4%
ROA
6.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,403,665,000 | 189,249,000 | 177,687,000 | 1,826,519,000 | 398,916,000 | 1,427,603,000 | 238,663,000 |
| Dec 2024 | 1,194,615,000 | 86,224,000 | 14,012,000 | 1,533,181,000 | 382,250,000 | 1,150,931,000 | 168,481,000 |
| Dec 2023 | 1,058,522,000 | 91,766,000 | 90,954,000 | 1,556,305,000 | 377,361,000 | 1,178,944,000 | 97,333,000 |
| Dec 2022 | 847,133,000 | 6,082,000 | -2,002,000 | 1,370,886,000 | 372,028,000 | 998,858,000 | -55,661,000 |
TTM Snapshot
Revenues TTM
$1,109,803,000
NetIncome TTM
$75,693,000
OpCashFlow TTM
$0
Assets (Latest)
$1,826,519,000
Forward EPS
$6.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | $12.14B | $23.49 | — |
| SNNUF | SMITH & NEPHEW PLC | $11.50B | $13.74 | — |
| SNN | SMITH & NEPHEW PLC | $11.33B | $27.08 | — |
| SOLV | Solventum Corp | $15.24B | $89.54 | — |
| ALGN | ALIGN TECHNOLOGY INC | $10.30B | $145.00 | — |
News headlines (Yahoo Finance, 1h cache)
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
2026-07-30 20:05 · Yahoo
IQV vs. PEN: Which Stock Is the Better Value Option?
2026-07-14 15:40 · Yahoo
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention
2026-07-24 12:30 · Yahoo
Reasons to Retain Penumbra Stock in Your Portfolio for Now
2026-09-16 13:13 · Yahoo
TFX vs. PEN: Which Stock Is the Better Value Option?
2026-09-11 15:40 · Yahoo
TFX or PEN: Which Is the Better Value Stock Right Now?
2026-08-26 15:40 · Yahoo
Which Medtech Giant Would Buy Inspire Medical Systems?
2026-08-14 21:54 · Yahoo
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
2026-08-06 18:16 · Yahoo
Penumbra (PEN) Following THUNDERBOLT Debut, Is The Stock A Bargain Or Fairly Valued
2026-07-26 05:13 · Yahoo
Penumbra (PEN) Wins FDA Clearance For THUNDERBOLT After Strong Stroke Study
2026-07-25 22:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.